Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1969 1
1970 1
1971 1
1972 1
1974 1
1975 2
1976 1
1977 3
1978 2
1979 8
1981 2
1982 6
1983 4
1984 10
1985 9
1986 8
1987 6
1988 14
1989 8
1990 8
1991 3
1992 6
1993 4
1994 4
1995 5
1996 1
1997 11
1998 15
1999 16
2000 9
2001 7
2002 13
2003 17
2004 13
2005 7
2006 9
2007 5
2008 11
2009 9
2010 4
2011 7
2012 5
2013 9
2014 11
2015 18
2016 10
2017 9
2018 17
2019 14
2020 20
2021 15
2022 16
2023 15
2024 17
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

419 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. Among authors: sako m. J Am Soc Nephrol. 2022 Feb;33(2):401-419. doi: 10.1681/ASN.2021050643. Epub 2021 Dec 8. J Am Soc Nephrol. 2022. PMID: 34880074 Free PMC article. Clinical Trial.
Imaging of Activated T Cells.
Sako MO, Larimer BM. Sako MO, et al. J Nucl Med. 2023 Jan;64(1):30-33. doi: 10.2967/jnumed.122.264097. Epub 2022 Dec 2. J Nucl Med. 2023. PMID: 36460341 Free PMC article. Review.
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan.
Akiyama S, Shimizu H, Tamura A, Yokoyama K, Sakurai T, Kobayashi M, Eizuka M, Yanai S, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sako M, Yoshida A, Tsuruta K, Yoshioka S, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. Akiyama S, et al. Among authors: sako m. Aliment Pharmacol Ther. 2025 Feb;61(3):524-537. doi: 10.1111/apt.18406. Epub 2024 Nov 22. Aliment Pharmacol Ther. 2025. PMID: 39578704
Rituximab for nephrotic syndrome in children.
Iijima K, Sako M, Nozu K. Iijima K, et al. Among authors: sako m. Clin Exp Nephrol. 2017 Apr;21(2):193-202. doi: 10.1007/s10157-016-1313-5. Epub 2016 Jul 15. Clin Exp Nephrol. 2017. PMID: 27422620 Free PMC article. Review.
Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis Patients over and under 65 Years of Age: A Real-World Comparative Analysis.
Akiyama S, Shimizu H, Tamura A, Yokoyama K, Sakurai T, Kobayashi M, Eizuka M, Yanai S, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sako M, Yoshida A, Tsuruta K, Yoshioka S, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. Akiyama S, et al. Among authors: sako m. Inflamm Intest Dis. 2025 Jun 24;10(1):180-186. doi: 10.1159/000546640. eCollection 2025 Jan-Dec. Inflamm Intest Dis. 2025. PMID: 40667521 Free PMC article.
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.
Akiyama S, Yokoyama K, Yagi S, Shinzaki S, Tsuruta K, Yoshioka S, Sako M, Shimizu H, Kobayashi M, Sakurai T, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sugai K, Yanai S, Yoshida A, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. Akiyama S, et al. Among authors: sako m. Aliment Pharmacol Ther. 2024 Jun;59(11):1413-1424. doi: 10.1111/apt.17961. Epub 2024 Mar 17. Aliment Pharmacol Ther. 2024. PMID: 38494867
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Among authors: sako m. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
[Lymphography].
Nishimine M, Sako M. Nishimine M, et al. Among authors: sako m. Geka Chiryo. 1972 Mar;26(3):291-301. Geka Chiryo. 1972. PMID: 5068385 Japanese. No abstract available.
Electrochemical synthesis of heterodehydro[7]helicenes.
Khalid MI, Salem MSH, Sako M, Kondo M, Sasai H, Takizawa S. Khalid MI, et al. Among authors: sako m. Commun Chem. 2022 Dec 3;5(1):166. doi: 10.1038/s42004-022-00780-7. Commun Chem. 2022. PMID: 36697698 Free PMC article.
419 results